Omeros gets orphan drug designation

Omeros said Monday that its drug OMS824 will get special incentives as regulators review the drug as a treatment for Huntington's disease.

http://www.miamiherald.com/2013/09/30/3660627/omeros-gets-orphan-drug-designation.html